CSTL
CASTLE BIOSCIENCES INC
Nasdaq Services-Medical Laboratories Accelerated filer

Key Financials

Operating Income
$-42810000
↓ 593.8%
Gross Profit
$53.0M
↑ 262.1%
Net Income
$-24158000
↓ 232.4%
Revenue
$344.2M
↑ 3.7%
EPS (Diluted)
$-0.83
↓ 233.9%
Total Assets
$578.6M
↑ 8.9%
Total Liabilities
$107.7M
↑ 42.8%
Long-term Debt
$10.1M
↑ 0.3%

Recent SEC Filings

Form Type Filed Date Link
4 8/18/2026 View on SEC
4 8/18/2026 View on SEC
CERT 8/17/2026 View on SEC
144 8/14/2026 View on SEC
144 8/14/2026 View on SEC
8-A12B 8/14/2026 View on SEC
4 8/6/2026 View on SEC
4 8/6/2026 View on SEC
4 8/5/2026 View on SEC
4 8/4/2026 View on SEC

Company Information

Field Value
Ticker CSTL
Company Name CASTLE BIOSCIENCES INC
CIK 1447362
Sector Services-Medical Laboratories
Industry Accelerated filer
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 866-788-9007